JANA SANDERS: Open Payments
NPI 1568530160 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 72 payments from 22 companies in 2025. Trend: 2023 $902 · 2024 $1,595 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Teva Pharmaceuticals USA, Inc. | 6 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| ABBVIE INC. | 6 | $134 |
| Otsuka America Pharmaceutical, Inc. | 5 | $125 |
| Alkermes, Inc. | 4 | $92 |
| Viatris Specialty LLC | 3 | $91 |
| Insmed, Inc. | 3 | $87 |
| Amgen Inc. | 4 | $79 |
Products named: AUSTEDO XR, GLASSIA, REXULTI, VRAYLAR, YUPELRI, Arikayce, FASENRA, NUCALA.
Industry payments across FL — which companies pay providers there.
